Wednesday, June 15, 2022 at 3:00pm to 4:00pm
Wednesday, June 15 3:00 - 4:00 PM CST
WATCH LIVE from any browser on June 15: https://utd.link/Research411
Learn about #UTDResearchImpact through outstanding faculty research sharing best practices during this interactive talk show!
Dr. Heather Hayenga joins the Office of Research and Innovation to discuss the need for systemic therapy to treat hemangiopericytoma (HPC), a rare nonhereditary brain tumor caused by an environmental fusion of two genes. She and her colleagues in the Vascular Mechanobiology Laboratory at UT Dallas are working to improve cancer therapies and delivery using genome editing, potential drug targets, and gene-targeted therapies to treat HPC brain tumors. Be our guest at this #UTDResearchImpact event!
No event registration is required - however, we encourage you to add this to your digital calendar of choice by clicking your preferred platform icon under 'Subscribe' in the gray section below.
Persons with disabilities may submit a request for accommodations to participate in this event at UT Dallas' ADA website. You may also call (972) 883-5331 for assistance or send an email to ADACoordinator@utdallas.edu. All requests should be received no later than 10 business days prior to the event.
Faculty & Staff, Alumni, General Public, Graduate Students, Undergraduate Students, Prospective Students